Neuropeptide-processing enzymes

Applications for drug discovery

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Neuropeptides serve many important roles in communication between cells and are an attractive target for drug discovery. Neuropeptides are produced from precursor proteins by selective cleavages at specific sites, and are then broken down by further cleavages. In general, the biosynthetic cleavages occur within the cell and the degradative cleavages occur postsecretion, although there are exceptions where intracellular processing leads to inactivation, or extracellular processing leads to activation of a particular neuropeptide. A relatively small number of peptidases are responsible for processing the majority of neuropeptides, both inside and outside of the cell. Thus, inhibition of any one enzyme will lead to a broad effect on several different neuropeptides and this makes it unlikely that such inhibitors would be useful therapeutics. However, studies with mutant animals that lack functional peptide-processing enzymes have facilitated the discovery of novel neuropeptides, many of which may be appropriate targets for therapeutics.

Original languageEnglish (US)
Title of host publicationDrug Addiction: From Basic Research to Therapy
PublisherSpringer New York
Pages497-509
Number of pages13
ISBN (Print)9780387766775
DOIs
StatePublished - 2008

Fingerprint

Drug Discovery
Neuropeptides
Enzymes
Protein Precursors
Cell Communication
Peptide Hydrolases
Peptides
Therapeutics

Keywords

  • carboxypeptidase
  • peptide biosynthesis
  • peptidomics
  • prohormone convertase

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Fricker, L. D. (2008). Neuropeptide-processing enzymes: Applications for drug discovery. In Drug Addiction: From Basic Research to Therapy (pp. 497-509). Springer New York. https://doi.org/10.1007/978-0-387-76678-2_29

Neuropeptide-processing enzymes : Applications for drug discovery. / Fricker, Lloyd D.

Drug Addiction: From Basic Research to Therapy. Springer New York, 2008. p. 497-509.

Research output: Chapter in Book/Report/Conference proceedingChapter

Fricker, LD 2008, Neuropeptide-processing enzymes: Applications for drug discovery. in Drug Addiction: From Basic Research to Therapy. Springer New York, pp. 497-509. https://doi.org/10.1007/978-0-387-76678-2_29
Fricker LD. Neuropeptide-processing enzymes: Applications for drug discovery. In Drug Addiction: From Basic Research to Therapy. Springer New York. 2008. p. 497-509 https://doi.org/10.1007/978-0-387-76678-2_29
Fricker, Lloyd D. / Neuropeptide-processing enzymes : Applications for drug discovery. Drug Addiction: From Basic Research to Therapy. Springer New York, 2008. pp. 497-509
@inbook{b075d58ee9894682937826e972825f3b,
title = "Neuropeptide-processing enzymes: Applications for drug discovery",
abstract = "Neuropeptides serve many important roles in communication between cells and are an attractive target for drug discovery. Neuropeptides are produced from precursor proteins by selective cleavages at specific sites, and are then broken down by further cleavages. In general, the biosynthetic cleavages occur within the cell and the degradative cleavages occur postsecretion, although there are exceptions where intracellular processing leads to inactivation, or extracellular processing leads to activation of a particular neuropeptide. A relatively small number of peptidases are responsible for processing the majority of neuropeptides, both inside and outside of the cell. Thus, inhibition of any one enzyme will lead to a broad effect on several different neuropeptides and this makes it unlikely that such inhibitors would be useful therapeutics. However, studies with mutant animals that lack functional peptide-processing enzymes have facilitated the discovery of novel neuropeptides, many of which may be appropriate targets for therapeutics.",
keywords = "carboxypeptidase, peptide biosynthesis, peptidomics, prohormone convertase",
author = "Fricker, {Lloyd D.}",
year = "2008",
doi = "10.1007/978-0-387-76678-2_29",
language = "English (US)",
isbn = "9780387766775",
pages = "497--509",
booktitle = "Drug Addiction: From Basic Research to Therapy",
publisher = "Springer New York",

}

TY - CHAP

T1 - Neuropeptide-processing enzymes

T2 - Applications for drug discovery

AU - Fricker, Lloyd D.

PY - 2008

Y1 - 2008

N2 - Neuropeptides serve many important roles in communication between cells and are an attractive target for drug discovery. Neuropeptides are produced from precursor proteins by selective cleavages at specific sites, and are then broken down by further cleavages. In general, the biosynthetic cleavages occur within the cell and the degradative cleavages occur postsecretion, although there are exceptions where intracellular processing leads to inactivation, or extracellular processing leads to activation of a particular neuropeptide. A relatively small number of peptidases are responsible for processing the majority of neuropeptides, both inside and outside of the cell. Thus, inhibition of any one enzyme will lead to a broad effect on several different neuropeptides and this makes it unlikely that such inhibitors would be useful therapeutics. However, studies with mutant animals that lack functional peptide-processing enzymes have facilitated the discovery of novel neuropeptides, many of which may be appropriate targets for therapeutics.

AB - Neuropeptides serve many important roles in communication between cells and are an attractive target for drug discovery. Neuropeptides are produced from precursor proteins by selective cleavages at specific sites, and are then broken down by further cleavages. In general, the biosynthetic cleavages occur within the cell and the degradative cleavages occur postsecretion, although there are exceptions where intracellular processing leads to inactivation, or extracellular processing leads to activation of a particular neuropeptide. A relatively small number of peptidases are responsible for processing the majority of neuropeptides, both inside and outside of the cell. Thus, inhibition of any one enzyme will lead to a broad effect on several different neuropeptides and this makes it unlikely that such inhibitors would be useful therapeutics. However, studies with mutant animals that lack functional peptide-processing enzymes have facilitated the discovery of novel neuropeptides, many of which may be appropriate targets for therapeutics.

KW - carboxypeptidase

KW - peptide biosynthesis

KW - peptidomics

KW - prohormone convertase

UR - http://www.scopus.com/inward/record.url?scp=84900177718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900177718&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-76678-2_29

DO - 10.1007/978-0-387-76678-2_29

M3 - Chapter

SN - 9780387766775

SP - 497

EP - 509

BT - Drug Addiction: From Basic Research to Therapy

PB - Springer New York

ER -